Plain-English translation of NCT07665424 on ClinicalTrials.gov ↗ · Source last updated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This clinical trial is testing the Vessel-X® Bone Filling Container System, a new device designed to treat vertebral compression fractures—painful spine fractures that occur in people with osteoporosis. The system uses a small, biocompatible container that is filled with bone cement to stabilize the fractured vertebra and reduce pain. Researchers are comparing this new treatment to the standard spine-stabilization procedure to see if it is safer and works just as well or better.
Osteoporotic spine fractures cause severe pain and disability, especially in older adults and postmenopausal women. While standard procedures can help, they carry risks like cement leaking outside the vertebra and incomplete restoration of spine height. This trial is testing whether the new container system can reduce these risks while still relieving pain and restoring spine function.
You likely qualify if…
You likely don't qualify if…
If you are selected for this trial, you will receive a minimally invasive procedure performed under real-time imaging guidance. Depending on which group you are randomly assigned to, you will either receive the new Vessel-X® container system filled with bone cement, or the standard vertebroplasty procedure using bone cement alone. Both procedures take place in an operating room, and you will be monitored for safety and symptom relief afterward through follow-up visits and assessments.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Taiwan